Novolog

The Novolog healthcare group has announced the departure of CEO Aviad Busi and CFO Yaniv Vidavsky. Zeev Mansour, formerly CEO of Logisticare, will take over as the new CEO in December.

The Pozis family is reshaping Novolog: following a board shake-up and the departure of key executives, Zeev Mansour has been appointed CEO. With extensive experience in logistics management, Mansour is tasked with improving the profitability of the company's core operations.

After leading a successful turnaround at his previous company and establishing a logistics center worth hundreds of millions of shekels, Zeev Mansour has been appointed to lead the Israeli logistics and medical group Novolog.

Novolog released its Q2 2026 results following a management overhaul and the consolidation of the Pozis family's control. Net profit dropped to 541,000 shekels from 4.6 million shekels in the same quarter last year, driven by higher financing expenses.

Novolog CEO Aviad Bosi and CFO Yaniv Vidavsky will leave their positions in four months. The departure follows the Pozis family's move to secure a 44% controlling stake and replace the board of directors. Oded Pozis is expected to spearhead a new strategic plan for the company.

The short power struggle at the medical services company Novolog has turned the spotlight on the battered stock, which lost 76% of its value at its peak, and on the successful entrepreneur who brought it to the stock exchange but prefers to operate under the radar. What went wrong in Novolog's success story, and can it get back on the path to success after the Pozis family's renewed takeover and...

A day after the control struggle was resolved, the chairman and board of directors of Novolog resigned. Oded Pozis, representing the controlling shareholder family, has been appointed chairman, with Ofer Linczewski, Doron Sela, and CPA Sagi Kaduri joining the board.

The Pozis family is acquiring an 18.2% stake in Novolog from Phoenix and Arkin at a 19% premium. The move comes as a counter-measure to Eli Dahan's attempt to invest 100 million shekels, which would have diluted the founding family's holdings.

A power struggle is unfolding at Novolog between controlling shareholder Ehud Pozis and businessman Eli Dahan. Dahan has proposed a 100 million shekel investment in exchange for a 21% stake in the company.

The Pozis family, controlling shareholders of Novolog, has accused the board of directors of attempting to entrench power through a 100 million shekel investment deal with the Movement group, sparking a corporate power struggle.

The Pozis family, controlling shareholders of Novolog, announced plans to replace the board of directors. This move triggered a power struggle and a 16.6% surge in the company's share price.

Novolog shares are surging amid a struggle for control. The Movement group has offered a 100 million shekel investment for a 21.34% stake, prompting controlling shareholder Ehud Pozis to attempt to dissolve the board to block the deal.

The company 'Movement', owned by Eli Dahan, has submitted an offer to purchase 21.34% of the shares of pharmaceutical distributor 'Novolog' in exchange for a 100 million shekel investment.